0001209191-23-057455.txt : 20231205
0001209191-23-057455.hdr.sgml : 20231205
20231205170018
ACCESSION NUMBER: 0001209191-23-057455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231205
DATE AS OF CHANGE: 20231205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krishnamohan Neha
CENTRAL INDEX KEY: 0001866171
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39743
FILM NUMBER: 231467412
MAIL ADDRESS:
STREET 1: 12707 HIGH BLUFF DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kinnate Biopharma Inc.
CENTRAL INDEX KEY: 0001797768
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824566526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11975 EL CAMINO REAL, STE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8582994699
MAIL ADDRESS:
STREET 1: 11975 EL CAMINO REAL, STE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-01
0
0001797768
Kinnate Biopharma Inc.
KNTE
0001866171
Krishnamohan Neha
103 MONTGOMERY STREET, SUITE 150
THE PRESIDIO OF SAN FRANCISCO
SAN FRANCISCO
CA
94129
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-12-01
4
F
0
1459
2.25
D
65593
D
The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of restricted stock units ("RSUs") granted to the Reporting Person by the Issuer.
Includes 46,407 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.
/s/ Mark A. Meltz, as attorney-in-fact
2023-12-05